167 related articles for article (PubMed ID: 26486970)
21. Radiotherapy-induced changes of peripheral blood lymphocyte subpopulations in cervical cancer patients: relationship to clinical response.
Eric A; Juranic Z; Tisma N; Plesinac V; Borojevic N; Jovanovic D; Milovanovic Z; Gavrilovic D; Ilic B
J BUON; 2009; 14(1):79-83. PubMed ID: 19373951
[TBL] [Abstract][Full Text] [Related]
22. NK1.1
Qian X; Hu C; Han S; Lin Z; Xiao W; Ding Y; Zhang Y; Qian L; Jia X; Zhu G; Gong W
J Cell Mol Med; 2017 Jul; 21(7):1431-1444. PubMed ID: 28224733
[TBL] [Abstract][Full Text] [Related]
23. Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.
Dai Z; Turtle CJ; Booth GC; Riddell SR; Gooley TA; Stevens AM; Spies T; Groh V
J Exp Med; 2009 Apr; 206(4):793-805. PubMed ID: 19289577
[TBL] [Abstract][Full Text] [Related]
24. Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis.
Capraru D; Müller A; Csernok E; Gross WL; Holl-Ulrich K; Northfield J; Klenerman P; Herlyn K; Holle J; Gottschlich S; Voswinkel J; Spies T; Fagin U; Jabs WJ; Lamprecht P
Clin Immunol; 2008 May; 127(2):144-50. PubMed ID: 18313361
[TBL] [Abstract][Full Text] [Related]
25. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
26. NKG2D- and CD28-mediated costimulation regulate CD8+ T cell chemotaxis through different mechanisms: the role of Cdc42/N-WASp.
Serrano-Pertierra E; Cernuda-Morollón E; López-Larrea C
J Leukoc Biol; 2014 Mar; 95(3):487-95. PubMed ID: 24168855
[TBL] [Abstract][Full Text] [Related]
27. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
28. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
29. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors.
Maccalli C; Scaramuzza S; Parmiani G
Cancer Immunol Immunother; 2009 May; 58(5):801-8. PubMed ID: 19089424
[TBL] [Abstract][Full Text] [Related]
30. Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis.
Fasth AE; Björkström NK; Anthoni M; Malmberg KJ; Malmström V
Eur J Immunol; 2010 Feb; 40(2):378-87. PubMed ID: 19904767
[TBL] [Abstract][Full Text] [Related]
31. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
32. Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells.
Jensen H; Folkersen L; Skov S
PLoS One; 2012; 7(8):e41577. PubMed ID: 22870231
[TBL] [Abstract][Full Text] [Related]
33. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
[TBL] [Abstract][Full Text] [Related]
34. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
Whitman E; Barber A
Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
[TBL] [Abstract][Full Text] [Related]
35. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
36. Expression of immune cell markers and tumor markers in patients with cervical cancer.
Zhang L; Zhang H; Huang Y; Xi X; Sun Y
Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
[TBL] [Abstract][Full Text] [Related]
37. CD3+ CD4+ and CD3+ CD8+ lymphocyte subgroups and their surface receptors NKG2D and NKG2A in patients with non-small cell lung cancer.
Yu DP; Han Y; Zhao QY; Liu ZD
Asian Pac J Cancer Prev; 2014; 15(6):2685-8. PubMed ID: 24761885
[TBL] [Abstract][Full Text] [Related]
38. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
[TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction.
Shabir S; Smith H; Kaul B; Pachnio A; Jham S; Kuravi S; Ball S; Chand S; Moss P; Harper L; Borrows R
Am J Transplant; 2016 Apr; 16(4):1113-28. PubMed ID: 26603521
[TBL] [Abstract][Full Text] [Related]
40. NK cells are primed by ANRS MVA(HIV)-infected DCs, via a mechanism involving NKG2D and membrane-bound IL-15, to control HIV-1 infection in CD4+ T cells.
Moreno-Nieves UY; Didier C; Lévy Y; Barré-Sinoussi F; Scott-Algara D;
Eur J Immunol; 2014 Aug; 44(8):2370-9. PubMed ID: 24777763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
